Literature DB >> 6434004

Different colony-stimulating factors are detected by the "interleukin-3"-dependent cell lines FDC-Pl and 32D cl-23.

A J Hapel, H S Warren, D A Hume.   

Abstract

The cell lines FDC-Pl and 32D cl-23 have previously been used as unique indicators for the growth-promoting activity of interleukin-3. We show that FDC-Pl cells respond to granulocyte/macrophage colony-stimulating factor (GM-CSF, CSF-2) as well as to interleukin-3. In keeping with this finding, FDC-Pl cells express the macrophage-specific marker, F4/80. FDC-Pl cells do not, however, respond to macrophage CSF (M-CSF, CSF-1). In contrast, 32D cl-23 cells do not respond to GM-CSF and lack F4/80. Instead, 32D cl-23 cells respond to an as yet undefined factor in conditioned medium (CM) from the primate T cell line, MLA-144, and CM from mitogen-stimulated human lymphocytes (HLCM). 32D cl-23 cells are Lyt-1+. Both FDC-Pl and 32D cl-23 cells consume interleukin-3, but only FDC Pl cells consume GM-CSF. Similarly, 32D cl-23, but not FDC-Pl, cells consume 32D cl-23 growth factor from MLA-144 CM and HLCM. Interleukin-3-dependent cell lines must therefore concurrently express different functional cell surface receptors for a variety of biochemically distinct growth factors.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6434004

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  21 in total

1.  Characterization of membrane homing receptors in two cloned murine hemopoietic progenitor cell lines.

Authors:  T Matsuoka; C Hardy; M Tavassoli
Journal:  J Clin Invest       Date:  1989-03       Impact factor: 14.808

2.  Concanavalin A-stimulated rat spleen cells produce a soluble factor that supports growth of the mouse IL-3-dependent cell line Ea3.123, but not three other IL-3-dependent lines.

Authors:  J A Carron; S Marshall-Clarke
Journal:  Immunology       Date:  1986-08       Impact factor: 7.397

3.  Differential inhibition of recombinant bovine GH (rbGH) activity in vitro by in vivo enhancing monoclonal antibodies.

Authors:  J Beattie; K Phillips; V Borromeo
Journal:  Mol Cell Biochem       Date:  2001-04       Impact factor: 3.396

4.  Lymphokine activity production in graft-versus-host reactions across minor histocompatibility antigen barriers.

Authors:  M Hirokawa; H Takatsu; A Ohshima; A Chubachi; K Kudo; H Niitsu; T Takahashi; K Yoshida; A B Miura
Journal:  Clin Exp Immunol       Date:  1989-09       Impact factor: 4.330

5.  Induction of macrophage colony-stimulating factor-dependent growth and differentiation after introduction of the murine c-fms gene into FDC-P1 cells.

Authors:  L R Rohrschneider; D Metcalf
Journal:  Mol Cell Biol       Date:  1989-11       Impact factor: 4.272

6.  Growth factor gene activation and clonal heterogeneity in an autostimulatory myeloid leukemia.

Authors:  K B Leslie; J W Schrader
Journal:  Mol Cell Biol       Date:  1989-06       Impact factor: 4.272

7.  Structure-function relationships of interleukin-3. An analysis based on the function and binding characteristics of a series of interspecies chimera of gibbon and murine interleukin-3.

Authors:  K Kaushansky; S G Shoemaker; V C Broudy; N L Lin; J V Matous; E M Alderman; J D Aghajanian; P J Szklut; R E VanDyke; M K Pearce
Journal:  J Clin Invest       Date:  1992-11       Impact factor: 14.808

8.  Interleukin 2-dependent release of interleukin 3 activity by T4+ human T-cell clones.

Authors:  A A Ythier; M Abbud-Filho; J M Williams; R Loertscher; M W Schuster; A Nowill; J A Hansen; D Maltezos; T B Strom
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

9.  FDC-P1 myeloid cells engineered to express fibroblast growth factor receptor 1 proliferate and differentiate in the presence of fibroblast growth factor and heparin.

Authors:  M Li; O Bernard
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-15       Impact factor: 11.205

10.  Characterization of unique lymphoid cells derived from murine spleen which constitutively produce interleukin-6.

Authors:  H C O'Neill; K Ni
Journal:  Immunology       Date:  1993-06       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.